| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Lingnau Lutz is a Director at NKTR. Recent filings cover 0 purchases and 13 sales. Those positions are worth an estimated $2.7M at current prices.
Lingnau Lutz's largest disclosed position is in NKTR as Director, worth about $2.7M. The recent filings there lean toward selling, a net 200,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2016 | NKTR Nektar Therapeutics | Director | Sale+OE | 15,000 | $14.51 | $217,650.00 | -47.7% | |
| Oct 28, 2015 | NKTR Nektar Therapeutics | Director | Sale+OE | 12,500 | $12.00 | $150,000.00 | -43.2% | |
| Jun 15, 2015 | NKTR Nektar Therapeutics | Director | Sale+OE | 25,000 | $11.15 | $278,750.00 | -60.3% |